MARTELLI, CECILIA
 Distribuzione geografica
Continente #
NA - Nord America 3.239
EU - Europa 1.840
AS - Asia 1.150
SA - Sud America 120
Continente sconosciuto - Info sul continente non disponibili 46
AF - Africa 34
OC - Oceania 25
Totale 6.454
Nazione #
US - Stati Uniti d'America 3.182
RU - Federazione Russa 617
IT - Italia 334
SG - Singapore 304
CN - Cina 290
IE - Irlanda 222
HK - Hong Kong 221
SE - Svezia 214
PL - Polonia 136
VN - Vietnam 102
BR - Brasile 100
KR - Corea 100
DE - Germania 76
FI - Finlandia 58
FR - Francia 57
IN - India 47
UA - Ucraina 44
GB - Regno Unito 41
CA - Canada 37
JP - Giappone 26
AU - Australia 25
BE - Belgio 15
TR - Turchia 15
CI - Costa d'Avorio 11
IQ - Iraq 10
MX - Messico 10
AR - Argentina 8
NL - Olanda 7
RO - Romania 7
JO - Giordania 6
NG - Nigeria 6
BD - Bangladesh 5
PK - Pakistan 5
EC - Ecuador 4
ID - Indonesia 4
NI - Nicaragua 4
PH - Filippine 4
BJ - Benin 3
CL - Cile 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
LT - Lituania 3
MA - Marocco 3
MU - Mauritius 3
ES - Italia 2
JM - Giamaica 2
PY - Paraguay 2
SA - Arabia Saudita 2
TN - Tunisia 2
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
CR - Costa Rica 1
CY - Cipro 1
EU - Europa 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
KH - Cambogia 1
KW - Kuwait 1
LY - Libia 1
MY - Malesia 1
PS - Palestinian Territory 1
SN - Senegal 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 6.409
Città #
Santa Clara 914
Ashburn 264
Chandler 237
Singapore 230
Dublin 221
Fairfield 186
Hong Kong 186
Warsaw 135
Woodbridge 103
Seoul 99
Cambridge 88
Ann Arbor 82
Jacksonville 81
San Jose 81
Milan 80
Houston 77
Seattle 72
Wilmington 69
Beijing 56
Council Bluffs 54
The Dalles 51
Hefei 49
Los Angeles 48
Buffalo 41
Princeton 40
Ho Chi Minh City 38
Rome 38
Boston 36
Lauterbourg 34
Mumbai 33
Munich 31
Tokyo 25
Altamura 24
Melbourne 24
Boardman 23
Lawrence 23
Florence 22
New York 21
Paris 20
Hanoi 19
Moscow 19
Dallas 18
Bologna 15
Brussels 15
Falls Church 15
Medford 14
Phoenix 14
Shanghai 14
San Diego 12
Abidjan 11
Chicago 11
Orem 11
Dearborn 10
Izmir 10
Columbus 9
Kent 9
São Paulo 9
Turin 9
Da Nang 8
Helsinki 8
Naples 8
Norwalk 8
Toronto 8
Guangzhou 7
Montreal 7
Redondo Beach 7
San Francisco 7
Tianjin 7
Turku 7
Washington 7
Abuja 6
Andover 6
Hillsboro 6
Baghdad 4
Brasília 4
Haiphong 4
London 4
Managua 4
Ottawa 4
Verona 4
Belo Horizonte 3
Bengaluru 3
Brooklyn 3
Cotonou 3
Curitiba 3
Düsseldorf 3
Edinburgh 3
Figino 3
Frankfurt Am Main 3
Frankfurt am Main 3
Grafing 3
Lappeenranta 3
Miano 3
Rio de Janeiro 3
Romola 3
Stockholm 3
Taranto 3
Trento 3
Venice 3
Algiers 2
Totale 4.374
Nome #
The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR) 331
N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR) 283
MOLECULAR MODULATION OF MUSCARINIC ANTAGONISTS. SYNTHESIS AND AFFINITY PROFILE OF 2,2-DIPHENYL-2-ETHYLTHIO-ACETIC ACID ESTERS DESIGNED TO PROBE THE BINDING SITE CAVITY 267
N,N-bis(cyclohexanol)amine aryl esters: a new class of highly potent Pgp-dependent multidrug resistance (MDR) inhibitors 224
Design, synthesis and preliminary biological evaluation of zatebradine analogues as potential blockers of the hyperpolarization-activated current 218
2-PYRROLIDINONE MOIETY IS NOT CRITICAL FOR THE COGNITION ENHANCING ACTIVITY OF PIRACETAM-LIKE DRUGS 215
New structure–activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR) 210
ISOMERIC N,N-BIS(CYCLOHEXANOL)AMINE ARYL ESTERS: THE DISCOVERY OF A NEW CLASS OF HIGHLY POTENT P-GLYCOPROTEIN (PGP)-DEPENDENT MULTIDRUG RESISTANCE (MDR) INHIBITORS 208
Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist. 208
Design, synthesis and nootropic activity of new analogues of sunifiram and sapunifiram, two potent cognition-enhancers. 206
Design, synthesis and pharmacological evaluation of some frozen-analogues of DMPP 189
N,N-bis(alkanol)amine aryl esters and N,N-bis(cyclohexanol)amine aryl esters: Idantification of a new class of Pgp-dependent multidrug resistance (MDR) reverters andowed with potencies in the nanomolar range 188
Diphenylcyclohexylamine derivatives as new potent multidrug resistance (MDR) modulators 184
MOLECULAR MODULATION OF MUSCARINIC ANTAGONISTS. SYNTHESIS AND PHARMACOLOGICAL PROFILE OF 2,2-DIPHENYL-2-ETHYLTHIOACETIC AND 3,3-DIPHENYL-3-ETHYLTHIOPROPIONIC ACID DERIVATIVES CHARACTERIZED BY A DIPEPTIDE SPACER 175
Inhibition of P-glycoprotein-mediated Multidrug Resistance (MDR) by N,N-bis(cyclohexanol)amine aryl esters: further restriction of molecular flexibility maintains high potency and efficacy 174
Exploratory chemistry toward the identification of a new class of MDR reverters inspired by pervilleine and verapamil models 165
Modulazione molecolare di antagonisti muscarinici. Sintesi e valutazione farmacologica preliminare di esteri amminoalchil piperazinici e piperidinici dell'acido 2,2-difenil-2-etiltioacetico 157
Inhibition of P-glycoprotein-mediated multidrug resistance (MDR) by N,N-bis(cyclohexanol)amine aryl esters: structure-activity relationships 153
Structure-activity relationship studies on unifiram (DM232) and sunifiram (DM235), two novel and potent cognition enhancing drugs 150
Synthesis, Affinity Profile and Functional Activity of Potent Chiral Muscarinic Antagonists with a Pyrrolidinylfuran Structure 150
Design and synthesis of multidrug resistance (MDR) inhibitors 148
Highly chiral muscarinic ligands: synthesis and affinity of diastereomeric and enantiomeric isomers of 1-methyl-2-(2-methyl-1,3-oxathiolane-5-yl)pyrrolidine 3-sulfoxides and their methyl iodides 140
SAR studies in a series of N,N-bis(arylaLKANOL)AMINE ARYL ESTERS AS p-GLYCOPROTEIN (Pgp) dependent multidrug resistance (MDR) inhibitors 137
The Novel Potent Multidrug Resistance Inhibitors N,N-bis(cyclohexanol)amine Aryl Esters Are Devoid of Vascular Effects 136
Structure-activity relationships studies in a series of N,N-bis(alkanol)amine aryl esters as P-glycoprotein (Pgp) dependent multidrug resistance (MDR) inhibitors 133
Sintesi e valutazione farmacologica di derivati furanici e tetraidrofuranici a potenziale azione muscarinica 133
synthesis, chiral HPLC separation and pharmacological characterization of muscarinic furan derivatives 133
Exploratory Chemistry toward the identification of new classes of MDR reverters 130
Rigid Analogs of DMPP As Probes For The Nicotinic Receptors 128
Molecular modulation of muscarinic antagonists. Synthesis and pharmacological profile of 2,2-diphenyl-2-ethylthioacetic acid and 3,3-diphenyl-3-ethylthiopropionic acid derivatives characterized by a dipeptide spacer 127
Isomeric N,N-(dicyclohexane-4-ol)amine aryl esters: the discovery of a new class of highly potent and efficacious Pgp-dependent MDR inhibitors 121
Isomeric N,N-dicyclohexane-4-ol-amine aryl esters: the discovery of a new class of highly potent and efficacious Pgp-dependent MDR inhibitors 121
Synthesis and pharmacological characterization of diastereomeric and enantiomeric isomers of 1-methyl-2-(2-methyl-1,3-oxathiolane-5-yl)pyrrolidine 3-sulfoxides and their methyl iodides 117
Isomeric N,N-dicyclohexane-4-ol-amine aryl esters: chemical and pharmacological development of highly potent and efficacious Pgp-dependent MDR inhibitors 116
Sintesi chirale e valutazione farmacologica preliminare degli enantiomeri di DM232 e MC68, due azabiciclononanoni modulatori dei processi cognitivi 108
Nuovi modulatori della multidrug resistance (MDR) a struttura difenilcicloesilaminica 103
Progettazione e sintesi di analoghi della Pervilleina A: una nuova classe di inibitori della Multidrug Resistance (MDR) 95
Optimization and structure-activity relationships of a new class of MDR reverters 92
Multidrug resistance (MDR) modulators: Verapamil offsprings and heterocyclic derivatives 91
Structure-activity relationships on N,N-dialkylaminoaryl esters, a new class of potent Pgp dependent multidrug resistance (MDR) inhibitors 90
Totale 6.454
Categoria #
all - tutte 17.571
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.571


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022244 0 0 29 11 8 8 14 15 9 8 71 71
2022/2023774 73 118 38 91 53 157 95 58 65 3 21 2
2023/2024297 16 28 40 12 7 89 8 66 3 3 9 16
2024/20251.981 65 175 118 245 643 427 14 116 33 50 35 60
2025/20261.729 212 265 145 65 211 90 194 69 106 85 34 253
2026/2027173 53 72 48 0 0 0 0 0 0 0 0 0
Totale 6.454